Phage display has enabled the rapid isolation of antigenspecific antibodies from combinatorial libraries of V H and V L genes obtained from lymphocytes of immunized animals. Recently, a different approach to antibody isolation that circumvents library screening and instead relies on the mining of the V H and V L gene repertoires obtained by high throughput sequencing of cDNAs from bone marrow antibody-secreting cells was reported. Here we compared the antibodies obtained via phage library screening or via repertoire mining of V gene cDNAs obtained from total splenocytes of mice immunized with the hapten trinitrophenyl (TNP) conjugated to carrier proteins. We show that, despite the large heterogeneity of B lymphocytes in the spleen, the most abundant V genes encoded antigen-specific antibodies, indicating that total splenocytes can be used in place of bone marrow plasma cells for antibody discovery at least in high titer animals. While both phage display and repertoire mining yielded antigen-specific antibodies showing comparable affinities by enzyme-linked immunosorbent assay analysis, clones obtained by the latter approach displayed higher selectivity towards TNP relative to control haptens. Interestingly, the antibody genes isolated by phage display were of low abundance or absent from the V gene repertoire obtained by 454 sequencing. Similarly, the highly abundant V genes identified by repertoire mining, that as soluble antibodies were antigen-specific, were found to be poorly displayed on phage and were not enriched by phage panning. Thus, our results reveal that phage display and repertoire mining of immune repertoires are complementary technologies that can yield different antigen-specific antibody clones.
Introduction
Recombinant antibodies may be recovered from one of three kinds of libraries: (i) naïve libraries constructed by amplification of variable (V) genes from B cells that had not intentionally exposed to a certain antigen. Such libraries present high levels of sequence diversity that can enable the isolation of binders towards a variety of antigens (McCafferty et al., 1990) . (ii) Immune libraries, where the variable heavy and variable light (V H and V L ) chains are amplified from B lymphocytes isolated from an immunized animal. In this case a significant portion of the antibodies in the library recognizes the immunogen (Barbas et al., 1991; ørum et al., 1993) . (iii) Synthetic libraries, whereby varying parts of the antibody domains are assembled from synthetic oligonucleotides that introduce complete or partial sequence degeneracy mainly into the CDR loops (Hoogenboom and Winter, 1992) . Similar to naïve libraries, synthetic libraries are usually large and diverse and may yield binders for many different antigens. Of the three, immune libraries are the richest source for antibodies that bind a desired antigen with high selectivity and affinity (Benhar, 2007) .
For obvious reasons, screening libraries of millions (or more) different antibodies is a daunting task. Hence, display technologies were harnessed as tools to enrich specific antibodies from a vast number of mostly antigen-irrelevant antibodies. All the display and selection platforms share four key steps: the generation (or cloning) of genetic diversity; the coupling of genotype to phenotype via the displaying platform; screening to enrich antibodies having the desired properties from the entire population and amplification of the enriched population following selection. The major types of selection platforms for antibody libraries are phage display, cell display, such as yeast (Boder and Wittrup, 1997) , bacterial display (Daugherty et al., 1999) , ribosome display (Hanes et al., 1998) and mammalian cell display (Beerli et al., 2008) .
Phage display is currently the most widespread method for the display and selection of large collections of antibodies and for the further engineering of selected antibodies. Antibodies are usually displayed in what is known as the 'monovalent' format, in which the antibody -coat protein fusion gene is carried on a phagemid vector and display is performed by infecting the phagemid-carrying bacteria with a helper phage. This format, also known as the 3 þ 3 format, is mostly preferred because constructing libraries in phagemid vectors offer higher transformation efficiency of phagemid vectors compared with phage vectors, as it provides for the selection of the highest affinity binders, which are not skewed by avidity effects (Barbas et al., 1991; Baca et al., 1997; O'Connell et al., 2002) .
Recently, we demonstrated that antigen-specific antibodies can be readily identified without screening, by exploiting high-throughput sequencing (HTS) of the V gene repertoire encoded by antibody secreting cells in the bone marrow of immunized mice. Shortly after booster immunization, the V gene repertoire of these cells becomes highly polarized with a few clones encoding antigen-specific V genes, each represented at frequencies 1 -20%. Pairing of the most abundant V H and V L sequences was shown to yield specific antibodies for a number of protein antigens (Reddy et al., 2010) . In addition, other reports have also highlighted the utility of HTS for evaluation of antibody libraries and for guiding the phage display screening process (Dias-Neto et al., 2009; Glanville et al., 2009; Ravn et al., 2010) .
Here we isolated antibodies by screening an immune library using phage display and compared them with antibodies identified from the relative abundance of the V H and V L genes following sequencing of the same antibody variable domains gene library by Roche 454 technology. In this study, libraries were constructed by amplifying pooled splenocytes from mice that were immunized with trinitrophenyl (TNP) conjugated to two different carriers. We found that phage display results in the isolation of antibodies which were barely detected in a set of .65 000 V H usable 454 V H reads from the same library, and conversely, mining of the V gene repertoire resulted in the identification of antigenspecific antibodies that had been missed by phage display. While all the antibodies isolated by the two methods displayed specificity and good affinity towards TNP, the clones identified by repertoire mining exhibited higher selectivity to TNP relative to the nitroamine explosives pentaerythritol tetranitrate (PETN) and 1,3,5-trinitroperhydro-1,3,5-triazine (RDX).
Materials and methods

Preparation of explosive analogs and conjugation to protein carriers
To prepare TNP-carrier conjugates, 2,4,6-trinitrophenyl-eaminocaproyl-OSu (Biosearch Technologies, CA, USA) was dissolved in dimethylsulfoxide (DMSO, Sigma, Israel) and mixed at a hapten/carrier molar ratio of 20 : 1 with either bovine serum albumin (BSA) (Serva, Germany) or human apotransferrin (Sigma, Israel) dissolved in phosphate-buffered saline (PBS: 8 g/l NaCl, 0.2 g/l KCl, 1.44 g Na 2 HPO 4 /l, 0.24 g/l KH 2 PO 4 , all chemicals were purchased from Merck KGaA, Germany). The mixture was placed on a rotating platform for 1 h, and was then dialyzed twice against 4 l of PBS using SnakeSkin Pleated Dialysis Tubing (Thermo Scientific, MA, USA) with a cutoff of 10 kDa. PETN or RDX conjugated to BSA or to apotransferrin were kindly provided by the lab of Prof. Fernando Patolsky (School of Chemistry, Tel-Aviv University, Israel). Briefly, the analogs were prepared by producing N-hydroxysuccinimide (NHS) ester derivatives of the explosives and mixing them with the carrier protein as described above. The PETN NHS ester was obtained by the initial alkylation of 1,3,5-trinitrohexahydropyrimidine. The reaction product was then converted to an acid by reaction with glutaric anhydride in the presence of 4-dimethylaminopyridine. Finally, NHS ester was produced by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)/NHS mediated coupling to apotransferrin. The RDX NHS ester was prepared by the nitration of pentaerythritol in a urea/ HNO 3 /H 2 SO 4 mixture, followed by a reaction with glutaric anhydride. The RDX NHS ester conjugation to apotransferrin was prepared as above.
Immunization of mice, RNA purification and cDNA synthesis Four female BALB/c mice (8 weeks old, 20 g body weight) were given intraperitoneal injections of 50 mg of BSA-TNP conjugated analog or BSA-PETN (2 mice received each analog) in complete Freund adjuvant (BD, NJ, USA) (Jackson and Fox, 1995) . After 2 weeks, the mice were boosted with another dose of 50 mg analog in incomplete Freund adjuvant (IFA; BD). Blood samples were collected 1 week after each immunization. After a total of three boosts, two of the mice (one for each hapten-carrier) were further boosted twice at 2-week intervals with human apotransferrin-conjugated to TNP or PETN, respectively. A week after the last boost the mice were sacrificed, spleens excised, the cell solubilized and total mRNA was produced from the mice with RNeasy protect midi kit (Qiagen, Germany) according to the manufacturer's instructions. The recovered RNA was converted to cDNA using the Superscript TM III first-strand synthesis kit (Invitrogen, CA, USA). All the animal experimentation was carried out with approval of the Tel-Aviv University IRB.
Construction of the phagemid library scFv libraries were constructed essentially as described previously (Benhar and Reiter, 2002) . Briefly, the library construction process consisted of three steps: (i) amplification of the V H and V L domains using framework region family-specific primers, (ii) re-amplification of each segment with primers containing the linker segment, (iii) assembly of both segments (V H and V L ) by overlap extension polymerase chain reaction (PCR). All PCR reactions were carried using the Expand High Fidelity PCR System (Roche Applied Science, Germany) according to the manufacturer's instructions. The PCR primers that were used had been reported earlier (Benhar and Reiter, 2002) . The PCR-assembled scFv DNA fragments from the TNP-immune repertoire were digested with NcoI and NotI restriction enzymes and were cloned in the pCC16 phagemid vector DNA (Azriel-Rosenfeld et al., 2004) that was previously digested with the same enzymes. The generated library was transformed via electroporation into freshly prepared Escherichia coli XL-1 Blue bacteria, which were spread over large 2 Â YT (16 g/l Bacto-Tryptone (BD), 10 g/l yeast extract (BD), 5 g/l NaCl) agar plates supplemented with 100 mg/ml ampicillin, 25 mg/ml tetracycline and 1% (w/v) glucose. After overnight incubation, the plates were scraped into a liquid medium (2 Â YT -ampicillintetracycline -1% glucose), and a phage rescue process was initiated as described. The electroporated bacteria were also titered by plating serial dilutions to assess the library size and the scapred bacteria were tittered similarly to assess the amplification of the library during the growth on plates.
Affinity selection ( panning) of phages
All the phage panning steps were carried out essentially as described previously (Benhar and Reiter, 2002) . Briefly, 1 ml of 5 mg/ml of the carrier-TNP conjugate was incubated in one well of a 24-well cell culture plate (Jet Biofil, China) overnight at 48C. The wells were washed with PBS containing 0.05% (v/v) Tween 20 (PBST, Sigma, Israel) and blocked with 3% (w/v) skimmed milk in PBS (blocking solution) for 2 h at 378C. Meanwhile, 10 12 CFU/ml of scFv-displaying M13 phages were incubated with a blocking solution for 1 h at room temperature. The coated wells were washed with PBST and incubated with the proper phages for 1 h at room temperature. The wells were washed with blocking solution diluted three times in PBST, and the remaining bound phage particles were eluted with 1 ml 0.1 M triethylamine, pH 13 (Fluka, Germany), for 30 min at room temperature on a rocking platform. The eluted phages were immediately neutralized with 200 ml of 1 M Tris-(HCl), pH 7.4. To prevent enriching phages that bind the blocking protein(s), the immune plates in each panning cycle were subjected to alternating blocking solutions consisting 3% (w/v) milk, 1% (w/v) BSA or 3% (w/v) gelatin in PBS. The phageblocking solution was changed between 1% BSA, 1% gelatin and 1% milk in PBS. After the fourth panning cycle, individual colonies of phagemid-carrying cells were used to prepare monoclonal phages in sterile 96-well plates (Nunc, Sweden) that were screened by phage enzyme-linked immunosorbent assay (ELISA).
Phage ELISA
Ninety-six-well ELISA plates (BioFil, China) were loaded with 100 ml of 5 mg/ml of the antigen in PBS and incubated overnight at 48C. The following day the plates were washed with PBST and blocked with a 3% skimmed milk in PBS solution for 2 h at 378C. After additional washing with PBST, 100 ml of freshly prepared phages were added per well and incubated for 1 h at room temperature. The plates were washed again with PBST, 100 ml of 1 : 5000 diluted horseradish peroxidase (HRP)-conjugated anti-M13 antibody (GE Healthcare, UK) were placed in each well for 1 h at room temperature, followed by additional washes with PBST and finally, 100 ml of 3, 3', 4, 4' -tetramethylbenzidine (TMB) (HRP substrate) solution (Dako, Denmark) were added to each well and incubated at room temperature. The reaction was stopped by the addition of 50 ml 1 M H 2 SO 4 to each well. The plate was analyzed with an EL X -800 plate reader (Bio-Tek instruments, VT, USA) at 450 nm. Phages that yielded ELISA signals that were at least 3 SD above background were selected as potential hits and validated by repeating phage ELISAs, where phages were applied with repetitions and dilutions.
HTS and data analysis of the V H and V L domains
The pool of V H and V L cDNA from splenocytes isolated from animals that had been immunized with BSA-TNP or with BSA-PETN and boosted with BSA-hapten followed by apotransferrin conjugates were recovered after the first PCR cycle of the phage library construction process. One hundred nanograms of each cDNA-derived PCR products of V H or V L domains were processed for Roche GS-FLX 454 DNA sequencing according to the manufacturer's protocol. All the 454 raw sequencing data were first processed using the sequence quality and signal filters of the 454 Roche pipeline and then subjected to bioinformatics analysis that relied on homologies to conserved framework regions and V germline gene identification using IMGT/HighV-Quest Tool (Lefranc, 2008;  http://www.imgt.org/HighV-QUEST/index.action). Additional filters were applied for full repertoire database construction as follows: (i) sequences without a valid V gene and allele were removed and (ii) for the purposes of germline V(D)J, CDR3 length and amino acid composition analyses, only sequences with n . 1 reads were considered. Identical CDR3s were grouped, and the high abundance sequences were clustered according to their somatic mutations along the entire V region.
After filtering the raw data to identify full length variable domains, the CDR3 sequences in the repertoire were rank-ordered based on their relative abundance. The most abundant CDR3s were selected. The most abundant CDR3 sequences in the TNP libraries were cross-referenced for their frequency in the PETN libraries in order to exclude CDR3 sequences that are abundant in both libraries from being tagged as 'TNP-specific'. Altogether, three V H and three Vk sequences were chosen (Table I ) and the respective genes were constructed by total gene synthesis using gene optimization for expression in E.coli (GeneArt, Germany). The most abundant V H was then fused in frame with the most abundant Vk in the scFv format. Similarly, the second and third ranked V H and V L were paired, respectively.
Expression and purification of Maltose-binding protein (MBP)-fused scFvs
For expression as soluble antibodies, scFv-coding genes were digested with NcoI and NotI restriction enzymes and cloned into pMALc-NN expression plasmid (Bach et al., 2001 ) that was digested with the same enzymes.
Escherichia coli BL21 Rosetta (DE3) cells (Merck KGaA) were transformed with pMALc-NN derivatives encoding fusions of desired scFvs to MBP and grown in 200 ml of Luria -Bertani medium (10 g/l Bacto-Tryptone, 5 g/l yeast extract, 10 g/l NaCl) supplemented with 100 mg/ml ampilcilin, at 378C with 250 rpm shaking to an OD 600nm of 0.8. The cells were chilled down to 308C and induced with 1 mM isopropyl-beta-thio galactopyranoside (Inalco, Italy) for 3 -4 h at 308C, 250 rpm. The cells were collected by centrifugation at 4200 Â g (at 5000 rpm, using a Sorvall GS3 rotor), at 48C for 10 min. The cell pellet was gently re-suspended in 35 ml of lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazol, adjusted to pH 8.0) and the cell suspension was sonicated on medium level with a W-385 sonicator (Misonix, Inc., NY, USA) until the lysate appeared clear. The lysate was then centrifuged for 30 min at 48C 12 000 rpm (Sorvall SS34 rotor), and the supernatant was poured into a column that was packed with 1 ml of Ni-NTA resin (Favorgen, Taiwan) that had been previously equilibrated with lysis buffer. The column was washed with 20 ml wash buffer (lysis buffer supplemented with 20 mM imidazol), 1 ml elution buffer (lysis buffer supplemented with 250 mM imidazol) was added and the eluate was collected and dialyzed twice against 4 l of PBS using SnakeSkin Pleated Dialysis Tubing with a cutoff of 10 kDa. For visualization of the purified proteins, 1 mg of each protein sample was electrophoresed alongside a molecular weight marker (Bio-Rad, CA, USA) on a 12% sodium dodecyl sulfate/polyacrylamide gel and were visualized by staining with Coomassie Blue R-250 solution (0.006% (v/v) Coomassie Brilliant blue R-250 (Sigma, MO, USA), 20% (v/v) ethanol, 10% (v/v) glacial acetic acid). The purified MBP fused proteins were stored in 50% (v/v) glycerol at 2208C.
Converting the scFvs that were isolated by HTS to phage displayed antibodies
For expression as phage-displayed antibodies, the scFvs that were synthesized according to the 454 HTS analysis (VH1-VK1, VH2-VK2 and VH3-VK3) were recovered by digesting DNA of the pMALc-NN expression plasmids with NcoI and NotI and sucbcloning the inserts into two phagemids that were digested with the same enzymes. One was the pCC16 phagemid that was the vector of the phage library described above. The second was pAKC (Benhar et al., 2000) , a phagemid that displayed the same scFv-CBD cassette as does pCC16, but that carries a chloramphenicol resistance gene instead of the ampicillin resistance gene carried on the pCC16 phagemid. The resulting phagemids, pCC-VH1-VK1, pCC-VH2-VK2, pCC-VH3-VK3, pAKC-VH1-VK1, pAKC-VH2-VK2 and pAKC-VH3-VK3 were introduced into E.coli and phages were prepared and evaluated for TNP-BSA binding by phage ELISA as described above. Briefly, 3 Â 10 11 phages/well and 3Â 2-fold dilutions thereof were applied into the well of an ELISA plate coated with 5 mg/ml TNP-BSA and blocked. Phages were detected with HRP-conjugated anti-M13 antibody (GE ) followed by TMB color reaction development as described above.
Simulated affinity selection of the phage library spiked with HTS-chosen clones
An affinity selection cycle on TNP-BSA immobilized onto wells of a 24-well plate was carried out as described above with the following modifications: to 10 12 pCC16 phages of the immune library we added separately 10 5 phages of clones pAKC-VH1-VK1, pAKC-VH2-VK2 and pAKC-VH3-VK3. Each mix was subjected to a single cycle of binding, washing and elution as described above for affinity selection of the library. Escherichia coli cells were infected by aliquots from the input and the output phages and plated on 2 Â YT-ampicillin agar plates (to count library phages) and on 2 Â YT-chloramphenicol agar plates (to count the spiked-in phages). The enrichment factor was calculated by comparing the ratio of ampicillin to chloramphenicol resistant phages before and after the affinity selection cycle (essentially as described in (Benhar et al., 2000) ).
Competition ELISA
A 96-well ELISA plate was prepared as described above for phage ELISA with the following adjustments. The wells were coated with either BSA or apotransferrin-conjugated haptens, scFv-MBP fusion proteins were pre-incubated for 1 h with serial dilutions of the competitor antigen, and then 100 ml of the antibody -antigen mixture were added to each well for 1 h at 378C. A monoclonal anti-maltose binding protein antibody (Sigma, USA) and a HRP-conjugated goat anti-mouse antibody (Jackson ImmunoResearch Laboratories, PA, USA) both diluted 5000-fold were used together as secondary antibodies. The IC 50 value was calculated as the antigen concentration at which 50% binding from the maximal binding score was achieved and this value is equal to the K D of the antibody towards the hapten according to the formula:
Results
Construction of the immune library
Four female BALB/c mice were given interperitoneal injections of either TNP or PETN conjugated to BSA or to apotransferrin as described in Materials and methods. Following the boosts with hapten-protein carrier conjugate in IFA, titers were determined towards TNP, PETN or RDX. A titer .1 : 2 Â 10 6 was observed for the two apotransferrin-TNP immunized mice relative to a titer of 1 : 27 000 towards apotransferrin. Similarly, titers of 1 : 240 000 and 1 : 81 000 were observed for animals immunized with apotransferrin-PETN towards apotransferrin-PETN and apotransferrin, respectively (Fig. 1A) . As shown in Fig. 1B , mice immunized with either carrier-TNP-or carrier-PETN-developed antibodies that were also partially cross-reactive to carrier RDX. In contrast, the two mice that were boosted with hapten-BSA and were not further boosted with hapten-apotransferrin showed similar serum antibody titers to BSA and to hapten-BSA conjugates. Therefore, these two mice were not further evaluated.
Following sacrifice, spleens were removed, and mRNA was isolated and used to prepare cDNA. The cDNA was then used as template for PCR amplification using family-specific primers corresponding to mouse antibody variable domains (heavy chain and kappa light chain) as described previously (Benhar and Reiter, 2002) . The PCR-amplified V H and V L domains of the anti-TNP library were used for Roche 454 sequencing and were also amplified using a second PCR step to assemble scFv genes in which the V H and V L domains were linked via a sequence encoding a (Gly 4 Ser) 3 linker. The assembled scFvs were cloned into the pCC16 phagemid vectors and transformed into E.coli XL-1 cells yielding a phagemid library size of 10 7 clones. The PCR-amplified variable domain genes from the splenocytes obtained from the mouse immunized with PETN were analyzed by Roche 454 sequencing (as described in Materials and methods).
Screening the immune anti-TNP library
The anti-TNP library was subjected to three rounds of phage panning. At the end of the last panning cycle we could recover four distinct phage clones displaying scFvs out a total of 10 3 phage clones that were screened by phage ELISA. These clones, named B9, C8, E10 and F10 were tested for their specificity to BSA-TNP, BSA-PETN and BSA-RDX by ELISA. As shown in Fig. 2 , the phage clones binding to TNP-BSA was significantly higher than to the other conjugates. Clones B9, C8, E10 and F10 were pairwise aligned with their corresponding germline gene and with each other. As shown in Fig. 3 , The V H segments of clones B9, C8 and E10 apparently originated from the same germline V gene (J558.33), while the V H of clone F10 originated from a different one (J558.1). Clones B9, C8 and E10 also have the same J segment (IGHJ4*01) and clone F10 has IGHJ2*01, while there are several options for the D segment and an assignment of the D segment could not be made with certainty. All the V segments were found to display 96% identity to their respective germline V genes. Clones B8 and C9 were virtually identical, with a single amino acid difference in V H . All the V L segments originated from the same germline gene (bb1), were 97 -99% identical to it and they all used the same J-kappa segment (IGKJ2*01) (Fig. 3D) .
The MBP-fused scFv form of the antibody encoded by clone E10, which gave the highest monoclonal phage ELISAs signal, was expressed and shown bind to PETN and RDX (Fig. 4) but displayed significantly more potent binding to the TNP analog. As evaluated by competition ELISA, the E10 scFv-MBP fusion protein displayed an IC 50 towards BSA-TNP of about 0.15 mM (Fig. 5) .
HTS of the immune libraries
The pools of V H and V L DNA from the TNP and PETN cDNA repertoires from total splenocytes were analyzed by Roche 454 DNA sequencing.
As shown in Table I , a total of 103 888 and 30 534 reads for the V H and Vk, respectively, were obtained from total splenocyte cDNA from the TNP-immunized mouse. Of the V H sequences, 63.1% contained an intact V H CDR3 (CDRH3), and 43.84% of the Vk sequences contained an intact CDR3 of Vk (CDRK3). The splenocyte cDNA from the PETN-immunized mouse yielded 79 822 and 65 767 reads for the V H and Vk regions, respectively. In all, 65.24 and 39.48% of the sequences contained a valid CDRH3 and CDRK3, respectively.
When the sequences of scFvs that were recovered by phage panning were compared with the HTS database, the CDRH3 of clone E10 (the best phage panning selected clone) was absent from the repertoire of CDR3Hs in the V H sequence set of the TNP-immunized mouse, and its CDRK3 showed low abundance (0.007%) in the HTS repertoire. The V H sequences of phage clones B9 and C8 were found 3 times (0.004%) in the HTS repertoire and that of clone F10 was not found. The V K sequence shared by phage clones B9, Fig. 1 . Titer and specificity of serum from the last bleed against apotransferrin analogs. (A) For titer determination, sera were diluted as mentioned and 100 ml of diluted serum was placed in a well pre-incubated with 5 mg/ml apotransferrin-TNP (1) or apotransferrin-PETN (2). In both cases, unconjugated apotransferrin was used as a control antigen. (B) Specificity, sera from immunized mice show high specificity towards the immunizing analog. Serum was diluted 6000 fold and 100 ml were placed in a well coated with 5 mg/ml of any of the apotransferrin analogs or apotransferrin. The data represents mean + standard error (n ¼ 4, **P value , 0.001).
Antibody isolation from immunized animals C8 and F10 was observed at a frequency .3% in the HTS data of both TNP and PETN. Therefore, it was disqualified from being tagged as 'TNP-specific. ' Each chosen variable segment was aligned with its ancestral germline gene, which was identified using the IgBLAST tool (http://www.ncbi.nlm.nih.gov/igblast). The V H segments of the highest scoring V genes originated from different germline genes: V H 1 was identical to its germline gene (VHSM7.a3.93) (Fig. 6A ) and for the D and J segments has IGHD1-1*02 and IGHJ1*01. Clone V H 2 had seven amino acid changes in comparison with its germline gene J558.34, four in the framework regions and three in CDRH1 and CDRH2 (Fig. 6B ) and for the D and J segments has IGHD1-1*02 (or IGHD5-5*01) and IGHJ1*01. Clone V H 3 had three amino acid changes in comparison with its germline gene J558.42, two in the framework regions and one in CDRH1 (Fig. 6C ) and for the D and J segments has DST4.2inv and IGHJ2*01. Clones Vk1 and Vk2 originated from the same germline gene, bj2, and had five amino acid substitutions compared with the germline, three of them in the framework regions and the rest in CDRL1 (Fig. 7A) . Clone Vk3 was identical to its germline gene bd2 (Fig. 7B) . All three light chain clones have the J segment IGKJ1*01.
Analysis of the clones chosen by HTS for antigen binding
The three scFvs containing the most highly abundant V H and V L domains from the anti-TNP sequence set were expressed as MBP fusions and purified. The purified scFvs-MBP fusions were analyzed for affinity to TNP and selectivity against PETN and RDX. All the scFv-MBP proteins demonstrated high specificity towards BSA-TNP (Fig. 8) . Binding to BSA-TNP by MBP-scFv V H 1-Vk1 could be competed with the non-conjugated TNP. The apparent K D of clone V H 1-Vk1 towards TNP in competition ELISAs was 0.15 mM (Fig. 9) , an affinity similar to that of the clones that were isolated by phage panning.
Evaluation of the clones chosen by HTS for antigen binding as phage displayed antibodies
To understand why the HTS chosen clones were not identified by phage panning, we carried out two experiments. In the first one, the scFvs from the three HTS chosen clones were subcloned into phagemid vectors, scFv-displaying phages were prepared and analyzed for TNP-BSA binding by phage ELISA. Phage clone E10 that was isolated by library phage panning served as a reference in the ELISA. As shown in Fig. 10 , the binding signal of the three HTS-chosen clones was negligible compared to the phage display selected clone.
In the second experiment we carried out a simulated affinity selection in which we spiked the anti-TNP immune phage library with the HTS-chosen clones. The phage library is cloned into a phagemid ( pCC16) that carries ampicillin resistance while the HTS-chosen clones were cloned into a phagemid ( pAKC) that carries chloramphenicol resistance (Benhar et al., 2000) . We could evaluate the enrichment of the HTS-chosen clones by comparing the ratio between ampicillin to chloramphenicol carrying phages before and after a cycle of affinity selection on immobilized TNP-BSA. As input for affinity selection we used 10 12 phages (with the library being 10 7 clones, representing 10 5 -fold representation of each library clone) spiked with 10 5 phages of the HTS-chosen clones. Affinity selection of each spiked library was carried out independently. The results were that while about 10 6 ampicillin-resistant colonies were found in the output each of the three affinity selections, not a single chloramphenicol-resistant colony was recovered, suggesting that as phage-displayed antibodies, the HTS-chosen clones were competed by the library phages. Combined, these results suggest that the three scFvs we chose as TNP-BSA binders by HTS and that as soluble MBP-scFvs were actually better than the scFvs that were selected by phage panning, were not compatible with phage display. Fig. 2 . Specificity of phage clones isolated from the anti-TNP immune library by affinity selection. The phage clones (100 ml of 10 11 CFU/ml per well) were tested for their ability to discriminate between the explosive analogs BSA-PETN, BSA-RDX, BSA-TNP (5 mg/ml each), and the control antigen BSA (5 mg/ ml). The assay was performed at least three times, and the given values represent a single chosen test. Bars represent mean + standard error (n ¼ 4,*P value , 0.05, **P value , 0.001). An alignment of the V L regions with their germline gene. The borders of the CDRs were placed according to the longest CDR. Black, identical alignment; gray, similar amino acids. Multiple sequence alignments of the VH and VL sequences were carried out using MUSCLE (Edgar, 2004) as implemented in Geneious (Drummond et al., 2012) .
Discussion
In this study we sought to compare the antibodies identified by mining the V gene repertoire as determined by HTS sequencing with those obtained by screening a phage display library that was constructed from the same V gene pool (obtained from a hyper-immunized animal). HTS sequencing has been used before to identify enriched antibodies in the course of screening synthetic libraries (Ravn et al., 2010) .
The V gene cDNA has several areas of high sequence variability, namely the CDR1 and CDR2, encoded in the V germline region, and CDR3 which is formed by recombination with the D and J segments of the immunoglobulin heavy locus (V and J for the light locus), with the addition of non-templated (N) nucleotides to coding ends in V(D)J recombination sites (Gellert, 1992) . The Roche 454 platform is currently the most suitable HTS platform for the sequencing of full-length antibody variable domain-coding cDNAs, since it produces long reads (at an average of .330 bp) that contain the entire V gene and for some reads even part of the constant region sequence (Suzuki et al., 2011) . In contrast to the study (Reddy et al., 2010) where the most abundant clones in the long-lived, bone marrow plasma cell compartment encode antigen-specific antibodies, in this work we elected to interrogate the V gene sequences of total splenocytes, without sorting any particular B cell subgroup. The mouse spleen is estimated to contain about 10 million B lymphocytes, the majority of which are naïve cells (Rolink et al., 1999) while the percentage of antibody secreting plasmablasts and plasma cells in the spleen is low (Minges Wols, 2006) . Nonetheless, considering that the transcription of antibodies in plasma cells is manyfold higher than in naïve B cells and memory B cells (Bhattacharya et al., 2007 , Igarashi et al., 2007 , mRNA from recently expanded, antigen-specific spleen plasmablasts may well be represented at a higher frequency than other V gene mRNAs. Consistent with this hypothesis, the most abundant V H CDR3s were detected at frequencies of 4.43, 3.16 and 2.66% (Table I ) of the total usable reads and following synthesis of the corresponding V genes and pairing with the most abundant V L genes were shown to encode TNP-specific antibodies. Thus, our results suggest that, at least for high titer animals as was the case with the mouse analyzed here, the antigen-specific V gene transcripts dominate the total splenocyte repertoire and therefore can be mined to generate specific antibodies. However, when the serum titer is lower as was the case in the study of Reddy et al. (2010) , the repertoire of isolated antigensecreting cells is likely to be more suitable for antibody discovery.
It may have seemed reasonable to expect to identify the antibodies that were isolated from the phage-panning experiments in the repertoire sequencing data. However, the V H domains of the phage clones were found at low frequencies or not at all in the HTS data. There are several possible explanations for this result: First, it is likely that the repertoire sequencing was not deep enough to cover the clones that were enriched by phage panning. A second possibility that cannot be discounted is that some of the clones selected by phage display might have originated not from the repertoire per se but from recombination events that occurred during the overlap PCR assembly step that was used to construct the scFvs. Considering the high homology among V genes, it is possible that template switching during the second PCR required for the preparation of the phage display library might have generated new clones not represented in the immune repertoire. What was quite striking though was the fact that the most highly abundant V H and V L genes in the repertoire, although they encode antigen-specific antibodies as shown here, were not identified by phage display. Phage display, is known to introduce a strong bias during the screening process since only clones that are compatible with display on phage, are not toxic and are expressed in soluble form in bacteria can be enriched. In fact high throughput sequencing of phagemid DNA from successive rounds of panning has revealed that many high affinity binding clones become de-enriched, presumably because of the fitness cost they impart on the host or phage (Ravn et al., 2010) . Likewise, Fig. 5 . Affinity of MBP-E10 towards BSA-TNP. The scFv (100 ml of 10 mg/ml per well) was incubated for 1 h with a different concentration of BSA-TNP or BSA, and subsequently the mixture was transferred to an ELISA plate pre-incubated with BSA-TNP (5 mg/ml). The IC 50 value was determined as the analog concentration for which the A 450 score is 50% from the maximal A 450 . The assay was performed at least three times, and the given values represent a single chosen test. Bars represent mean + standard deviation (n ¼ 4). Fig. 4 . Specificity of MBP-E10 towards analogs of explosives. The scFv MBP-E10 (100 ml of 10 mg/ml per well) was tested by ELISA for its ability to discriminate between the explosive analogs BSA-TNP, BSA-PETN, BSA-RDX (coated at 5 mg/ml each), and the control antigen BSA (5 mg/ml). The assay was performed at least three times, and the given values represent a single chosen test. Bars represent mean + standard error (n ¼ 4, **P value , 0.001).
our inability to isolate phage clones encoding the highly abundant and antigen specific V H genes identified by HTS suggests that the respective scFvs must had been subjected to negative selective pressure due to one or more of the biological filters above. Indeed, when we tested the scFvs that were chosen by HTS for their ability to be displayed on phage or to be enriched by affinity selection, we found that they were displayed very poorly on phage (Fig. 10) and were selected against in a The borders of the CDRs were placed according to the longest CDR. Black, identical alignment; gray, similar amino acids. Multiple sequence alignments of the V H and V L sequences were carried out using MUSCLE (Edgar, 2004) as implemented in Geneious (Drummond et al., 2012) . The borders of the CDRs were placed according to the longest CDR. Black, identical alignment; gray, similar amino acids. Multiple sequence alignments of the V H and V L sequences were carried out using MUSCLE (Edgar, 2004) as implemented in Geneious ( (Drummond et al., 2012) . simulated affinity selection of a spiked phage library. These findings lead us to propose that while antibody phage display is still a very useful and powerful technology for antibody isolation, it may miss several immunogen-specific antibodies elicited by the immune system and repertoire mining is probably a better approach to access such antibodies. When repertoire mining is applied, it is critical to use a reference database to exclude highly abundant antibodies that are not immunogen-specific. The best reference database is from pre-immunization B cells collected from the same animal. This may not always be possible when bone marrow of spleen cells are the source of the B cells analyzed post-immunization by HTS. In such a case, a solution like the one we used here of using an animal that was immunized with a different antigen may provide an acceptable alternative.
There can be several reasons why phage display and repertoire mining may yield different antibodies for the same antigen. Each step of phage display is prone to biases (Jung et al., 1999; Desiderio et al., 2001) , some of which were observed in our study. To name a few: biases begin already during library construction (Sblattero and Bradbury, 2000; Holt et al., 2000) as a result of PCR-based bias in amplification of different templates, during the subsequent PCR amplifications used for assembly of scFvs and due to the fact that actual library size falls short of covering all possible combinations of V H and V L domains present in the cDNA. Second, some scFvs display better on phage than others (Malone and Sullivan, 1996; Pavoni et al., 2007; Scott et al., 2008) , as is shown in our evaluation of the three HTS-chosen clones that displayed very poorly on phage. Third, the affinity selection process itself is very sensitive to varying conditions and experimental variations (Hoogenboom et al., 1999; de Wildt et al., 2000; Smith et al., 2005) , frequently leading to different antibodies being isolated for a particular antigen by different individuals or even by the same individual under slightly varying experimental conditions. Finally, one should bear in mind that combinatorial mixing of V H and V L antibody domains in the process of library construction and 454 sequencing of V H and V L domains separately are very unlikely to recover the original H-L chain pairs that were present in the immunized animal. True probing of an immune repertoire is currently possible only by single-cell reverse transcriptase-PCR done on antigen-sorted B cells (Tiller et al., 2008) and is practiced only by a few experts. The need for recovering, at the population level, the heavy and light chain sequences without losing the original pairs is still unmet. Fig. 9 . Affinity of clone V H 1-Vk1 towards the TNP analog. The scFv V H 1-Vk1 (100 ml of 10 mg/ml per well) was incubated for 1 h with a different concentration of BSA-TNP or BSA, and subsequently was transferred to an ELISA plate pre-incubated with BSA-TNP (5 mg/ml). The IC 50 value was determined as the explosive concentration for which the A 450 score is 50% from the maximal A 450 . The assay was performed at least three times, and the given values represent a single chosen test. Bars represent mean + standard deviation (n ¼ 4). A 96-well ELISA plate was coated with 5 mg/ml of TNP-BSA and the ELISA was process as described in Materials and methods. Briefly, 3 Â 10 11 phages/well and 3Â 2-fold dilutions thereof (concentrations indicated in the inset) were applied into the wells coated and blocked plate and phages were detected with HRP-conjugated anti-M13 antibody followed by TMB color reaction. Error bars represent the standard error of the data. The evaluated phages were the three HTS-chosen clones as phage-displayed antibodies compared with the phage display-selected clone E10.
